DexCom Inc (NASDAQ: DXCM) has reported earnings for its third fiscal quarter (ending September 30) of $0.34 versus $0.31 for the same period a year ago — an increase of 10%. E.P.S. were $1.75 for the latest four quarters through September 30 versus $0.98 for the same period a year ago — an increase of 79%.
Recent Price Action
On 10/24/24, DexCom Inc (NASDAQ: DXCM) stock enjoyed a large increase of 3.3%, closing at $74.85. Moreover, exceptionally high trading volume at 225% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 7.1% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, DXCM is expected to continue to be a major Value Builder.
DexCom has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. DexCom has a poor Appreciation Score of 20 and a very low Power Rating of 7, leading to the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment